LONGEVITY with Nathalie Niddam cover image

Episode #102: Hybrid Peptides, Peptide Research Updates, and Bioregulators

LONGEVITY with Nathalie Niddam

00:00

Is Bimasenalpaon in the Mainstream Medicine?

It would have to get broken down for it even make it to ok. Just parenthesis throws it back to theehe hybrid. The future is that paracinical companies will be able to patent those hybrids, because they're not ally made. But the other thing is, of course, they're going to sell them expensive ut you know, insurance and things. Actually, looking at it this way, bright future, i agree.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app